Skip to main content
. 2011 Mar 21;17(1):51–60. doi: 10.3350/kjhep.2011.17.1.51

Table 1.

Prospective studies evaluating the use of drug-eluting beads loaded with doxorubicin (DEBDOX) for the treatment of hepatocellular carcinoma (HCC)

graphic file with name kjhep-17-51-i001.jpg

AE, adverse events; RR, response rates.